Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and ...
Patients with the deadliest form of brain cancer who received a focused ultrasound treatment to aid drug delivery increased their odds of survival by nearly 40%, according to research led by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback